Diversifying the vaccine development pipeline has been recognized as a priority in the Global TB Vaccine R&D Roadmap. The TBVAC-HORIZON consortium has successfully secured funding for a [...]
With the TBVI Award, TBVI encourages promising scientists and rewards their remarkable contributions to tuberculosis (TB) vaccine research and development, by offering them the opportunity to [...]
Would you like to present your work at the TBVI Annual Symposium? To encourage promising scientists and recognise outstanding contributions to TB vaccine research and development, TBVI presents [...]
Following the call for vaccine researchers to submit their vaccine candidate for testing in a mouse model, we are delighted to announce the selection of three candidates. Based on predetermined [...]
On May 27-28 2024, the second progress meeting of the MTBVACN3 project took place in Pilanesberg, near Johannesburg in South Africa. During these days the consortium partners met to share [...]
Runderweg 6
8219 PK Lelystad
The Netherlands
Email: info@tbvi.eu
Phone: 0031 (0)6 1099 5196
